In trading on Tuesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 8.1% on the day. Components of that ETF showing particular strength include shares of Intellia Therapeutics, up about 18.1% and shares of Fate Therapeutics, up about 15.6% on the day.
And underperforming other ETFs today is the First Trust Preferred Securities and Income ETF, up about 0.3% in Tuesday afternoon trading. Among components of that ETF with the weakest showing on Tuesday were shares of United States Cellular, lower by about 0.5%.
VIDEO: Tuesday’s ETF Movers: ARKG, FPE
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
www.nasdaq.com